Immunethep is a startup based in Portugal. Brouky records 1 investor associated with the company.
Immunethep develops immunotherapies to enhance the host immune response against bacterial infections, targeting antimicrobial resistance. Its pipeline includes multivalent preventive and therapeutic products such as vaccines and monoclonal antibodies for infectious diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.